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PERSPECTivES
The Role of Non-Profits in the Mammogram
Debate 
Jeyandini Fernando
With immediate access to new information on breast cancer research, more and more peo-
ple are turning to non-profits for guidance. With no template describing exactly how to find
a cure for such a destructive disease, it is hard for the general public to understand all the
twists and turns along the way. Non-profits play off their emotional connection to educate on
the scientific side of cancer research. Women and those affected by the disease have come
to rely on these organizations to find support, information, and, eventually, a cure. This per-
spective piece follows the non-profit world full circle to try to better understand the fondness
masses have toward non-profit organizations.
The spotlight was cast on breast can-
cer on December 6, 2010, when it was re-
ported that doctors had advised Elizabeth
Edwards not to continue with anti-cancer
treatments. Edwards had become a survival
advocate as she publicly fought the disease
from her diagnosis in 2004, and she re-
mained  a  pillar  of  strength  through  her
then-husband’s presidential campaign. Ed-
wards died the day after the statement was
released, and the loss of such a resilient
woman who had so much fight in her rein-
forced  difficult  questions.  As  Nancy
Brinker,  Susan  G.  Komen  for  the  Cure
founder, eloquently stated, “Elizabeth Ed-
wards’ death reminds us that there is still
plenty to worry about, that our exponential
progress is still not total victory over a dis-
ease that will kill 40,000 women in the
United States and 10 times that number
worldwide” [1].
Perhaps a major component included
in the “plenty to worry about” category is
the  frequent  change  in  advice  given  to
women on when to begin getting mammo-
grams. While new research developments
are reported that prompt public discussion,
contradictory advice about such things as
when women should begin having mam-
mograms can be confusing. Many women
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The View: “At some point, someone is going
to have to make a decision about when they
think it’s okay!” 
Notably, in November 2009, the U.S.
Preventive Services Task Force (USPSTF)
assessed that there are few benefits from
mammograms for women ages 40-49 and
recommended that women without a high
risk of breast cancer have mammograms
every other year rather than annually. Less
than one year later, in September 2010, the
New York Times brought attention to a study
from Norway that concluded that mammo-
grams do not necessarily decrease the mor-
tality rate of breast cancer. As new data
questioning established medical protocol is
reported, women are increasingly seeking
clarification from such non-profit organiza-
tions as Susan G. Komen for the Cure and
the Breast Cancer Research Fund (BCRF). 
Since its inception in 1982, Komen has
been dedicated to keeping women informed
about breast cancer and releasing prompt re-
sponses  to  new  research  developments,
while the BCRF is a leading contributor to
genetic susceptibility research and one of the
first organizations to expand its base to more
than 24 countries across the globe. In re-
sponse to the USPSTF’s report, Dr. Dara
Richardson-Heron, CEO of the Greater New
York City Affiliate of Susan G. Komen for
the Cure (Komen GNYC), said on the orga-
nization’s blog, “Because we still do not
know what causes breast cancer, early de-
tection is the only hope for survival” [2].
The blog post addressed the specific claims
under question and included a national state-
ment, opinions from prominent members of
Komen GNYC’s Medical Advisory Board,
and statements from public officials. Komen
GNYC also was flooded with questions and
requests for clarification after the New York
Times article about the Norway study was
published. In a September 23, 2010, post on
the Komen GNYC website, the Medical Ad-
visory Board stated, “We certainly under-
stand that mammograms are not perfect but
they are currently our best tool for early de-
tection and risk assessment. We also agree
and fully support more research to identify
screening tools that will be more effective,
sensitive and specific than mammography”
[3].
Women also turned to other trusted or-
ganizations for guidance on this ambiguous
issue, including the American Cancer Soci-
ety, American Congress of Obstetricians and
Gynecologists, and American College of Ra-
diology. Dr. J. Leonard Lichtenfeld, deputy
chief medical officer for the national office
of the American Cancer Society, encouraged
women to continue getting routine mammo-
grams: “We have a public health recom-
mendation that we believe has saved lives,
and we don’t believe the evidence is suffi-
cient to change that position” [4]. Mean-
while, Dr. Carol Lee, chairwoman of the
Breast Imaging Commission of the Ameri-
can College of Radiology, expressed frus-
tration about the new questions surrounding
mammography: “We have tried so hard to
encourage women for years to get screening
mammograms, and I’m worried that this will
set back the cause and result in a decreased
utilization of a tool that we know can save
lives” [4].
Along with the confusion of trying to
understand cancer’s complexity, many are
confused by the constant reporting of such
findings. “The truth is: science is not exact,”
Anita McFarlane, Director of Grants and
Public Policy at Komen GNYC, points out,
and that leads to continuously evolving re-
search findings. The USPSTF is “simply re-
porting findings. As a government-funded
organization, they have to report the data
they find and we have a right to know their
progress.” Richardson-Heron agrees, stating
that “informing the general public can shed
light on the confusion and eliminate much
of the anger that results from it.” Making re-
search reports public has shown many ben-
efits, including allowing others to see the
process in its entirety, opening the floor to
collaboration, and bringing light to addi-
tional questions that can be researched fur-
ther.
To some, it is hard to believe that a non-
profit organization has achieved this level of
prominence with the public and the media
alike. As to how it does this, McFarlane
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pelling  story  that  resonates  with  every
woman. Since it is focused on one cancer, it
can focus all our attention on hitting it from
all angles. Most importantly, we provide ac-
cess through more than one mean: educa-
tion,  awareness,  grant-funding,  and
advocacy.” Richardson-Heron adds, “The
money is where the mouth is, and it shows in
the gains made through research, in legisla-
tion, and the increase number of survivors.”
Meanwhile,  the  BCRF  is  praised  for  its
grants geared toward scientific progress. In
the fiscal year 2010-2011, “the Foundation
is proud to be funding 172 of the most bril-
liant scientists who are developing innova-
tive ideas at every level to build upon their
individual discoveries and to find new syn-
ergies to advance breast cancer research”
[5]. Hand-in-hand contributing to scientific
progress  and  encouraging  survivors  and
their families, Komen and BCRF prove that
finding a cure is a combined effort. With ac-
cess to new information, more contributors
can  collaborate  and  the  hope  for  a  cure
seems more possible.
However, not all breast cancer experts
agree with these organizations. In her article
titled  “Why  You  Might  Not  Need  a
Mammo”  in  the  October  2010  issue  of
Health Magazine, Ginny Graves profiled Dr.
Laura Esserman, a nationally known breast
surgeon at the University of California, San
Francisco (UCSF) Medical Center. Esser-
man had published an article in the Journal
of the American Medicine Association in
October 2009 regarding routine mammo-
grams.  “Routine  mammograms,”  Graves
wrote in the Esserman profile, “find too
many unusual-looking clusters of cells that
turn out to be benign, leading to unnecessary
biopsies. . . .What’s more, all of our inten-
sive screening efforts result in many women
being treated for tumors that might never
have become life-threatening” [4]. Esserman
believes that “if we take a watch-and-wait
approach to more patients who have low-
risk findings on their mammograms, we can
probably do a third fewer biopsies. . . .The
goal is to be able to personalize choices, ex-
plain the options, and let women decide how
much  intervention  they’re  comfortable
with” [4]. 
Awaiting science’s ability to provide
concrete evidence on the success of new
methods, women and their families continue
to rely on the tools non-profits are able to
provide in the interim. Terri DeMartis was
38 when she was diagnosed with breast can-
cer. For 15 years, she battled a cancer that
spread throughout her body, and the De-
Martis family turned to non-profits to learn
more about her condition, treatment, and
progress. Her daughter Laura, who was 7
when her mother was diagnosed, said, “We
immediately got involved with Gilda’s Club
(now affiliated with Cancer Support Com-
munity and the Wellness Community), the
American Cancer Society, Susan G. Komen
for the Cure, SHARE. My mother preferred
American Cancer Society because of their
fun activities such as Look Good . . . Feel
Better and various support groups she at-
tended. Gilda’s Club (located in Hacken-
sack, N.J.) was another non-profit that she
looked to in the early years of her diagnosis.
There, she went to support groups and re-
ceived support for her and our family.”
Laura and her family remained involved
after Terri died on April 11, 2009. “After she
passed, these same organizations helped me
just because I was still able to stay focused
on them and stay surrounded by those af-
fected by cancer,” Laura said. “Non-profits
help so much because they exist to help oth-
ers by providing information and making the
information as available as possible.” 
The DeMartis family is a prime exam-
ple of why non-profits are so important in
the progress toward finding a cure: People
are drawn to the emotional help that they
offer. Actually seeing and meeting survivors
and families who have suffered a loss paints
a more accurate picture of the effect this dis-
ease has. “Non-profits brought and continue
to bring clarity to me about the importance
of life,” Laura said. “They provide perspec-
tive. Non-profits bring me clarity because
they bring me back to reality if I begin to
slip on seeing what is really and truly im-
portant  in  life.”  Though  there  are  no
recorded numbers of how many people turn
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sponsors more than 122 races throughout the
United States with more than 1.3 million an-
nual participants, clearly showing how many
people believe in its mission. This emotional
bond has built a trust that is often relied on
when innovation is reported.
As non-profit organizations fund scien-
tists who discover new information through
their research, reports on that research by
several different circuits can make progress
seem far more confusing than intended. The
search for clarity continues to send floods of
women back to the non-profits they love and
trust.
Author’s note: As an intern with the Greater
New York City Affiliate of Susan G. Komen for
the Cure for more than a year, i was exposed
to the reaction to the release of innovative re-
ports. i gained a thorough understanding of
the role non-profits play and the process that
takes research and turns it into a proven
method. it took me a long time to understand
the intricacies of progress. i feel that if more
people had the opportunity to take on such
an experience, the confusion would be made
so much clearer.
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